We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.


Top UK endocrinologist joins the team

Leading endocrinologist Professor Neil Hanley has been appointed by the Trust's Research & Innovation (R&I) Division.

Professor of Endocrinology Prof Hanley and his research group have been at the forefront of studies in human endocrine development and stem cell biology. They were the second group in the world to report on cells consistent with human embryonic germ cells. These studies on the early human germ cell lineage provide information that translates clinically into improved understanding of germ cell tumours (GCT). The group's stem cell research is also focused on the long-term goal of generating pancreatic beta cells from embryonic stem (ES) cells, either as potential therapy or as background knowledge that facilitates advances in endogenous beta cell regeneration in patients.

Collaboration with industry is also a key component of Prof Hanley's work. As part of a government and pharmaceutical industry consortium, he is studying the human fetal liver and pancreas using patented novel 3-D air-liquid interface cultures. The aim is ultimately to improve drug toxicology screening in the pharmaceutical industry. Prof Phil Baker, clinical head of the R&I Division commented:

"Our ability to attract clinicians and researchers who lead their field is a testament to Manchester's excellent reputation for patient-driven research, "

" Appointing Neil is major coup for our growing team, and he brings a tremendous wealth of both research and clinical expertise."

Neil Hanley studied pharmacology, medicine and surgery at the University of Edinburgh from 1990 to 1996. He subsequently gained a PhD in molecular genetics from the University of Newcastle in 2001. From 1998 to 2000 he was Visiting Fellow to the laboratory of Dr. Keith Parker, Division of Endocrinology & Metabolism, University of Texas Southwestern Medical Center at Dallas, Texas. Prof Hanley then took up senior appointments at the University of Southampton from 2000, and became Honorary Consultant Endocrinologist at Southampton University Hospitals NHS Trust in 2004.